Sign in

NCT07428395Enrolling by invitation

Feasibility of Intradialytic Monitoring During CKRT

Feasibility of Intradialytic Hematocrit and Oxygen Saturation Monitoring During Continuous Kidney Replacement Therapy

Source: ClinicalTrials.gov · Last updated 6 May 2026

Brief summary (registry, in English)

This is a pilot observational cohort study to understand whether advanced monitoring techniques can be applied during continuous kidney replacement therapy (CKRT), which is the most common form of dialytic therapy provided in critically ill patients.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
30 (estimated)
First submitted
10 Feb 2026
Start date
17 Mar 2026
Primary completion date
31 Mar 2028
Lead sponsor
University of Pennsylvania
NCT number
NCT07428395

What you commit to

  • Study type: Observational
  • Planned participants: 30
  • From 17 Mar 2026 to the primary completion date, 31 Mar 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who are prescribed other forms of CKRT, namely continuous venovenous hemofiltration (CVVH), slow continuous ultrafiltration (SCUF), or prolonged intermittent kidney replacement therapy (PIKRT).

Other

  • Patients who have femoral vein dialysis catheters placed.
  • Patients who cannot provide consent or have a legal proxy to provide consent.

Who the study is looking for

  • Patients who have been admitted to the Medical ICU or Cardiothoracic ICU at the Hospital of the University of Pennsylvania (HUP).
  • Patients who have been prescribed continuous venovenous hemodialysis (CVVHD) or Continuous Veno-Venous Hemofiltration (CVVH), the predominant modalities of continuous kidney replacement therapy (CKRT) at HUP.
  • Patients who have central venous catheters placed in either the left or right internal jugular veins.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.